Rachel Wuerstein, MD | Authors

Articles

Next Steps for Trastuzumab Emtansine After the KAMILLA Trial

January 23, 2023

Rachel Würstlein, MD, discusses the use of trastuzumab emtansine following the KAMILLA trial which evaluated the agent in patients with HER2-positive locally advanced or metastatic breast cancer who have brain metastases.